Use of varicella vaccines to prevent Herpes Zoster in older individuals

Archives of Virology, Supplement

Volumn , Issue 17, 2001, Pages 151-160

  Levin, M J ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

AGED; CELLULAR IMMUNITY; CLINICAL TRIAL; ELDERLY CARE; HERPES ZOSTER; HUMAN; IMMUNOLOGY; REVIEW; TIME;

AGED; CHICKENPOX VACCINE; CLINICAL TRIALS; HEALTH SERVICES FOR THE AGED; HERPES ZOSTER; HUMANS; IMMUNITY, CELLULAR; TIME FACTORS;

EID: 0035228663     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6259-0_16     Document Type: Article

References (37)

1. Arvin AA, Koropchak CM, Wittek AE (1993) Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis 148: 200-205
2. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S (1994) Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94: 524-526
3. Berger R, Amstutz I, Just M, Just V, Luescher D (1985) Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response. Antiviral Res [Suppl] 1: 267-271
4. Berger R, Florent G, Just M (1981) Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 32: 24-27
5. Berger R, Luescher D, Just M (1984) Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine. J Infect Dis 149: 647-648
6. Berger R, Luescher D, Just M (1985) Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination. Postgrad Med J Postgrad Med J: 61: 143-145
7. Berger R, Trannoy E, Hollander G, Bailleux F, Rudin C, Creusvaux H (1998) A dose-response study of live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J Infect Dis 178 [Suppl 1]: S99-S103
8. Burke BL, Steele RW, Beard OW (1982) Immune responses to varicella-zoster in the aged. Arch Intern Med: 142: 291-293
9. Derryck A, LaRussa P, Steinberg S, Capasso M, Pitt J, Gershon AA (1998) Varicella and zoster in children with human immunodeficiency virus infection. Ped Infect Dis J 17: 931-933
10. Dolin R, Reichman RC, Mazur MH, Whitely RJ (1978) Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 89: 375-388
11. Donahue JG, Choo PW, Manson JE, Platt R (1995) The incidence of herpes zoster. Arch Intern Med 155: 1605-1609
12. Gershon AA, Steinberg SP (1981) Antibody responses to varicella-zoster virus and the role of antibody in host defense. Am J Med Sci 282: 12-17
13. Gershon AA, Steinberg, NIAID Varicella Vaccine Collaborative Study Group (1990) Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. J Infect Dis 161: 661-666
14. Hata S (1980) Skin test with varicella-zoster virus antigen on herpes zoster patients. Arch Dermatol Res 268: 65-70
15. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M (1984) Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 149: 956-963
16. Hayward A, Levin MJ, Wolf W, Angelova G, Gildend (1991) Varicella-zoster virus-specific immunity after herpes zoster. J Infect Dis 163: 873-875
17. Hayward AR, Buda K, Jones M, White CJ, Levin MJ (1996) VZV specific cytotoxicity following secondary immunization with live or killed vaccine. Clin Immunol 9: 241-245
18. Hayward AR, Buda K, Levin MJ (1994) Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol 7: 31-36
19. Hayward AR, Giller R, Levin MJ (1989) Phenotype, cytotoxic and helper functions of T cells from varicella zoster stimulated cultures of human lymphocytes. Viral Immunol 2: 175-184
20. Hayward AR, Pontesilli O, Herberger, Laszlo M, Levin M (1986) Specific lysis of VZV infected B lymphoblasts by human T cells. J Virol 65: 179-184
21. Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58: 9-20
22. Kawasaki H, Takayama J, Ohira M (1996) Herpes zoster infection after bone marrow transplantation in children. J Pediatr 128: 353-356
23. Krause PR, Klinman DM (1995) Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr 127: 518-525
24. Levin MJ, Hayward AR (1996) Prevention of herpes zoster. Infect Dis Clin North Am 10: 657-675
25. Levin MJ, Barber D, Goldblatt E, Jones M, La Fleur B, Chan C, Stinson D, Zerbe GO, Hayward AR (1998) Use of live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect. J Infect Dis 178 [Suppl 1]: S109-S112
26. Levine MJ, Ellison MC, Zerbe GO, Barber D, Chan C, Stinson D, Jones M, Hayward AR (2000) Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older. Vaccine 18: 2915-2920
27. Lieu TA, Black SB, Rieser N, Ray P, Lewis EM, Shinefield HR (1994) The cost of childhood chickenpox: parents' perspective. Pediatr Infect Dis J 13: 173-177
28. Ljungman R, Lonnqvist B, Gahrton G, Ringdén O, Sundqvist V-A, Wahren B (1986) Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis 153: 840-847
29. Miller AE (1980) Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30: 582-587
30. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO (1982) Population-based study of herpes zoster and its sequelae. Medicine 61: 310-316
31. Redman RL, Nader S, Zerboni L, Liu C, Wong RM, Brown BW, Arvin AM (1997) Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 176: 578-585
32. Rogers RS III, Tindall JP (1971) Geriatric herpes zoster. J Am Geriar Soc 19: 495-504
33. Somekh E, Levin, MJ (1993) Identification of human dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine. J Med Virol 40: 241-243
34. Sperber SJ, Smith BV, Hayden FG (1992) Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine. Antiviral Res 17: 214-222
35. Starr SE, Tinklepaugh C, Bocks E, Miller D, Rudenstein M, Plotkin SA (1987) Immunization of healthy seropositive middle aged and elderly adults with varicella-zoster virus (VZV) vaccine. (abstract no. 1237). In Programs and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, p 313
36. Yawn BP, Yawn RA, Lydick E (1997) Community impact of childhood varicella infections. J Pediatr 130: 759-765
37. Zhang Y, Cosyns M, Levin MJ, Hayward AR (1994) Cytokine production in varicella zoster virus stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 98: 128-133